{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:54:50Z","timestamp":1755226490047,"version":"3.43.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00520-025-09807-w","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T02:43:02Z","timestamp":1753929782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone for 12\u00a0weeks for reducing fatigue in patients receiving palliative chemotherapy: A Phase 3, Placebo-Controlled, Randomized Controlled Trial"],"prefix":"10.1007","volume":"33","author":[{"given":"Venkatraman","family":"Radhakrishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhya","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gundrathi Vamsi","family":"Vihari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Siva Kiran Kumar","family":"Dasapathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayachandran","family":"Perumal Kalaiyarasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendran","family":"Veeraiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swaminathan","family":"Rajaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"9807_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11864-020-0707-5","volume":"21","author":"MSY Thong","year":"2020","unstructured":"Thong MSY, van Noorden CJF, Steindorf K, Arndt V (2020) Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol 21:17. https:\/\/doi.org\/10.1007\/s11864-020-0707-5","journal-title":"Curr Treat Options Oncol"},{"key":"9807_CR2","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00520-015-2763-0","volume":"23","author":"LN Saligan","year":"2015","unstructured":"Saligan LN, Olson K, Filler K et al (2015) The biology of cancer-related fatigue: a review of the literature. Support Care Cancer 23:2461\u20132478. https:\/\/doi.org\/10.1007\/s00520-015-2763-0","journal-title":"Support Care Cancer"},{"key":"9807_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","volume":"11","author":"JE Bower","year":"2014","unstructured":"Bower JE (2014) Cancer-related fatigue\u2013mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11:597\u2013609. https:\/\/doi.org\/10.1038\/nrclinonc.2014.127","journal-title":"Nat Rev Clin Oncol"},{"key":"9807_CR4","doi-asserted-by":"publisher","first-page":"CD013782","DOI":"10.1002\/14651858.CD013782.pub2","volume":"1","author":"A Sandford","year":"2023","unstructured":"Sandford A, Haywood A, Rickett K et al (2023) Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer. Cochrane Database Syst Rev 1:CD013782. https:\/\/doi.org\/10.1002\/14651858.CD013782.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"9807_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/nrclinonc.2013.147","volume":"10","author":"R Kirk","year":"2013","unstructured":"Kirk R (2013) Palliative care: steroids to combat fatigue. Nat Rev Clin Oncol 10:546. https:\/\/doi.org\/10.1038\/nrclinonc.2013.147","journal-title":"Nat Rev Clin Oncol"},{"key":"9807_CR6","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","volume":"31","author":"S Yennurajalingam","year":"2013","unstructured":"Yennurajalingam S, Frisbee-Hume S, Palmer JL et al (2013) Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31:3076\u20133082. https:\/\/doi.org\/10.1200\/JCO.2012.44.4661","journal-title":"J Clin Oncol"},{"key":"9807_CR7","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.2217\/fon-2020-0853","volume":"17","author":"U Deb","year":"2021","unstructured":"Deb U, Mukhopadhyay S, Bhattacharya B et al (2021) Efficacy and safety of modafinil versus dexamethasone in cancer-related fatigue: a prospective randomized controlled study. Future Oncol 17:1735\u20131747. https:\/\/doi.org\/10.2217\/fon-2020-0853","journal-title":"Future Oncol"},{"key":"9807_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00520-016-3499-1","volume":"25","author":"S Jeyaram","year":"2017","unstructured":"Jeyaram S, Veeraiah S, Elangovan V (2017) Validation of the symbolic assessment of fatigue extent (SAFE)-a cancer fatigue tool with visual response formats. Support Care Cancer 25:1111\u20131119. https:\/\/doi.org\/10.1007\/s00520-016-3499-1","journal-title":"Support Care Cancer"},{"key":"9807_CR9","doi-asserted-by":"publisher","unstructured":"Weis J, Tomaszewski KA, Hammerlid E, et al (2017) International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12). J Natl Cancer Inst 109. https:\/\/doi.org\/10.1093\/jnci\/djw273","DOI":"10.1093\/jnci\/djw273"},{"key":"9807_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365\u2013376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"key":"9807_CR11","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm. Accessed 15 Apr 2022"},{"key":"9807_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11864-022-01045-0","volume":"24","author":"P Stone","year":"2023","unstructured":"Stone P, Candelmi DE, Kandola K et al (2023) Management of fatigue in patients with advanced cancer. Curr Treat Options Oncol 24:93\u2013107. https:\/\/doi.org\/10.1007\/s11864-022-01045-0","journal-title":"Curr Treat Options Oncol"},{"key":"9807_CR13","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1200\/JCO.2013.54.3926","volume":"32","author":"O Paulsen","year":"2014","unstructured":"Paulsen O, Klepstad P, Rosland JH et al (2014) Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. J Clin Oncol 32:3221\u20133228. https:\/\/doi.org\/10.1200\/JCO.2013.54.3926","journal-title":"J Clin Oncol"},{"key":"9807_CR14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1017\/S1478951514001254","volume":"13","author":"K Eguchi","year":"2015","unstructured":"Eguchi K, Honda M, Kataoka T et al (2015) Efficacy of corticosteroids for cancer-related fatigue: a pilot randomized placebo-controlled trial of advanced cancer patients. Palliat Support Care 13:1301\u20131308. https:\/\/doi.org\/10.1017\/S1478951514001254","journal-title":"Palliat Support Care"},{"key":"9807_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jpainsymman.2024.01.037","volume":"67","author":"K Miyazaki","year":"2024","unstructured":"Miyazaki K, Ikenaga M, Sato T et al (2024) A Randomized controlled trial of betamethasone on fatigue in patients with advanced cancer. J Pain Symptom Manage 67:393-401.e1. https:\/\/doi.org\/10.1016\/j.jpainsymman.2024.01.037","journal-title":"J Pain Symptom Manage"},{"key":"9807_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/oncolo\/oyac184","volume":"27","author":"S Yennurajalingam","year":"2022","unstructured":"Yennurajalingam S, Azhar A, Lu Z et al (2022) Open-label placebo for the treatment of cancer-related fatigue in patients with advanced cancer: a randomized controlled Trial. Oncologist 27:1081\u20131089. https:\/\/doi.org\/10.1093\/oncolo\/oyac184","journal-title":"Oncologist"},{"key":"9807_CR17","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1038\/s41598-018-20993-y","volume":"8","author":"TW Hoenemeyer","year":"2018","unstructured":"Hoenemeyer TW, Kaptchuk TJ, Mehta TS, Fontaine KR (2018) Open-label placebo treatment for cancer-related fatigue: a randomized-controlled clinical trial. Sci Rep 8:2784. https:\/\/doi.org\/10.1038\/s41598-018-20993-y","journal-title":"Sci Rep"},{"key":"9807_CR18","doi-asserted-by":"publisher","unstructured":"Junior PNA, Barreto CMN, de Iracema Gomes Cubero D, Del Giglio A (2020) The efficacy of placebo for the treatment of cancer-related fatigue: a systematic review and meta-analysis. Support Care Cancer 28:1755\u20131764. https:\/\/doi.org\/10.1007\/s00520-019-04977-w","DOI":"10.1007\/s00520-019-04977-w"},{"key":"9807_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4103\/ijph.ijph_1025_22","volume":"67","author":"A Poopady","year":"2023","unstructured":"Poopady A, Nayak S, D\u2019Silva F et al (2023) Cancer related fatigue measurement scales: a systematic review. Indian J Public Health 67:448. https:\/\/doi.org\/10.4103\/ijph.ijph_1025_22","journal-title":"Indian J Public Health"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09807-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T02:43:04Z","timestamp":1753929784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09807-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["9807"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09807-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ASCO 2023 annual meeting.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Presentation"}},{"value":"The Cancer Institute (W.I.A) Ethics Committee reviewed and approved the study protocol on 25 July 2018 (Reference number: IEC\/2018\/08). The study procedures adhered to the ethical standards of conduct outlined in the 2013 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"730"}}